Clinical Trial Update: SGLT-2 Inhibitor Empagliflozin Effects on Appetite and Weight Regulation. [Phase 4]

View source ↗

Summary

Phase 4 trial update examining empagliflozin effects on appetite and weight regulation in adults with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: University of Leicester | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED